United States · FDA National Drug Code directory
QUVIVIQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80491-7850_10e24e38-5645-433d-a160-82f4ed5b6dfb
- Product NDC
- 80491-7850
- Form
- TABLET, FILM COATED
- Composition / generic term
- Daridorexant
- Labeler
- Idorsia Pharmaceuticals Ltd
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220407
- Source listing expiry
- 20271231
Source-listed ingredients
- DARIDOREXANT — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (80491-7850-2) / 7 TABLET, FILM COATED in 1 BLISTER PACK · 80491-7850-2
- 1 BOTTLE in 1 CARTON (80491-7850-3) / 30 TABLET, FILM COATED in 1 BOTTLE · 80491-7850-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →